Compare PIPR & BCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PIPR | BCPC |
|---|---|---|
| Founded | 1895 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Major Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 4.8B |
| IPO Year | N/A | N/A |
| Metric | PIPR | BCPC |
|---|---|---|
| Price | $339.13 | $153.74 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $362.50 | $176.00 |
| AVG Volume (30 Days) | 126.2K | ★ 221.1K |
| Earning Date | 01-30-2026 | 02-20-2026 |
| Dividend Yield | ★ 1.71% | 0.63% |
| EPS Growth | ★ 42.49 | 22.48 |
| EPS | ★ 13.30 | 4.57 |
| Revenue | ★ $1,717,433,000.00 | $1,013,548,000.00 |
| Revenue This Year | $17.11 | $10.41 |
| Revenue Next Year | $15.11 | $5.89 |
| P/E Ratio | ★ $25.55 | $33.56 |
| Revenue Growth | ★ 13.46 | 7.55 |
| 52 Week Low | $202.91 | $139.17 |
| 52 Week High | $374.77 | $177.40 |
| Indicator | PIPR | BCPC |
|---|---|---|
| Relative Strength Index (RSI) | 45.73 | 44.26 |
| Support Level | $346.02 | $155.62 |
| Resistance Level | $355.55 | $158.59 |
| Average True Range (ATR) | 8.57 | 3.36 |
| MACD | -1.57 | -0.31 |
| Stochastic Oscillator | 7.82 | 7.94 |
Piper Sandler Cos is an investment bank and institutional securities firm, serving the needs of corporations, private equity groups, public entities, non-profit entities and institutional investors in the United States (U.S.) and internationally. The company provides a broad set of products and services, including financial advisory services; equity and debt capital markets products; public finance services; institutional brokerage services; fundamental equity and macro research services; fixed income services; and alternative asset management strategies. It generates maximum revenue from Advisory services followed by Equity financing.
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.